ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 117 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,000 | -64.0% | 2,700 | -59.7% | 0.00% | -100.0% |
| Q1 2022 | $25,000 | +31.6% | 6,700 | +857.1% | 0.00% | 0.0% |
| Q4 2021 | $19,000 | -17.4% | 700 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $23,000 | -17.9% | 700 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $28,000 | +600.0% | 700 | -12.5% | 0.00% | – |
| Q3 2020 | $4,000 | -94.7% | 800 | -87.7% | 0.00% | -100.0% |
| Q2 2020 | $76,000 | +245.5% | 6,500 | -4.4% | 0.01% | +400.0% |
| Q1 2020 | $22,000 | +214.3% | 6,800 | +1033.3% | 0.00% | – |
| Q4 2019 | $7,000 | -77.4% | 600 | -86.8% | 0.00% | -100.0% |
| Q3 2019 | $31,000 | – | 4,545 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |